|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
The Proteasome Inhibitor Bortezomib
Enhances the Activity of Docetaxel in Orthotopic Human Pancreatic
Tumor Xenografts
|
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |